BioSpace News Archive

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with a proprietary line of functional “supplement” chewing gums (versions: infused with CBD, CBG, Vitamin C & Zinc) and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that it is now a Registered Whole Foods Market, Inc. (“Whole Foods”) Vendor (“Supplier”). The Co

Origami Therapeutics http://origamitherapeutics.com , an early stage biotech company taking a precision medicine approach to find disease-modifying treatments for neurodegenerative diseases caused by protein folding, announced today it has been selected as one of the 60 “Cool Companies” for 2020 by Connect with San Diego Venture Group. Ori

Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences Company, with a proprietary line of functional “supplement” chewing gums (versions: infused with CBD, CBG, Vitamin C & Zinc) and edibles product(s) as well as two ongoing Biotechnology initiatives, today announced that it is taking concrete steps to expand into the fast growing Cannabidiol (“CBD”) infused pet food(s) market segment.

Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that it has received Chinese regulatory approval for the Edwards SAPIEN 3 transcatheter heart valve for the treatment of patients suffering from severe, symptomatic aortic stenosis (AS) at high risk for or unable to undergo open-heart surgery.

Eli Lilly and Company will participate in the Goldman Sachs 41st Annual Global Healthcare Conference on Wednesday, June 10, 2020.

BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced that it has entered into a securities purchase agreement with institutional investors to purchase approximately $6.9 million of its common stock in a registered direct offering priced at-the-market under Nasdaq rules and warrants to purchase common stoc

Tower Health Transplant Institute performed its first organ transplant at Reading Hospital on Monday, May 25.

- Crinecerfont Demonstrates Meaningful Reductions in Key Disease Biomarkers After 14 Days of Treatment - Initiation of Global Registrational Study of Crinecerfont in Adults Planned for Second Half 2020 [08-June-2020] SAN DIEGO , June 8, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced positive data from its completed op

June 8, 2020 15:00 UTC Onduo Announces Multiple Presentations at the American Diabetes Association 80 th Scientific Sessions: A Virtual Experience Studies show benefit of continuous glucose monitoring BOSTON--( BUSINESS WIRE )-- Today, Onduo announced that they will present three abstracts at the American Diabetes Association (ADA) 80 th Scientific Sessions: A Virtual Experience , June 12-16, discussing the Onduo Virtual Diabetes clinic which uses intermittent continuous

The U.S. Food & Drug Administration (FDA) reversed its position on the use of N95 masks that have been decontaminated on Sunday, June 7, aligning with the Massachusetts Nurses Association’s longstanding opposition to these unproven and potentially dangerous practices.